OAPI's professionals are conducting
research in the gastrointestinal therapeutic area with a focus on a
treatment for inflammatory bowel disease.
Ulcerative colitis is a chronic (ongoing) disease of the colon, or large
intestine. The disease is marked by inflammation and ulceration of
the colon, mucosa, or inner most lining. Tiny open sores, or
ulcers, form on the surface of the lining where they bleed and produce
pus and mucus. Because the inflammation makes the colon empty
frequently, symptoms typically include diarrhea (sometimes bloody) and
often crampy abdominal pain.
The inflammation usually begins in the rectum and lower colon, but it
may also involve the entire colon. When ulcerative colitis affects only
the lowest part of the colon -- the rectum -- it is called ulcerative
proctitis. If the disease affects only the left side of the colon, it is
called limited or distal colitis. If it involves the entire colon, it is
termed pancolitis.
Ulcerative colitis differs from another inflammatory bowel disease (IBD),
Crohn's disease. Crohn's can affect any area of the gastrointestinal
(GI) tract, including the small intestine and colon. Ulcerative colitis,
on the other hand, affects only the colon. The inflammation involves the
entire rectum and extends up the colon in a continuous manner. There are
no areas of normal intestine between the areas of diseased intestine. In
contrast, such so-called "skip" areas may occur in Crohn's disease.
Ulcerative colitis affects only the innermost lining of the colon,
whereas Crohn's disease can affect the entire thickness of the bowel
wall.
Both illnesses do have one strong feature in common. They are marked by
an abnormal response by the body's immune system. The immune system is
composed of various cells and proteins. Normally, these protect the body
from infection. In people with IBD, however, the immune system reacts
inappropriately. Mistaking food, bacteria, and other materials in the
intestine for foreign or invading substances, it launches an attack. In
the process, the body sends white blood cells into the lining of the
intestines, where they produce chronic inflammation. These cells then
generate harmful products that ultimately lead to ulcerations and bowel
injury. When this happens, the patient experiences the symptoms of IBD.
Neither ulcerative colitis nor Crohn's disease should be confused with
irritable bowel syndrome (IBS), a disorder that affects the motility
(muscle contractions) of the colon. Sometimes called "spastic colon" or
"nervous colitis," IBS is not characterized by intestinal inflammation.
It is, therefore, a much less serious disease than ulcerative colitis.
IBS bears no direct relationship to either ulcerative colitis or Crohn's
disease.
The first symptom of ulcerative colitis is a progressive loosening of
the stool. The stool is generally bloody and may be associated with
crampy abdominal pain and severe urgency to have a bowel movement. The
diarrhea may begin slowly or quite suddenly. Loss of appetite and
subsequent weight loss are common, as is fatigue. In cases of severe
bleeding, anemia may also occur. In addition, there may be skin lesions,
joint pain, eye inflammation, and liver disorders. Children with
ulcerative colitis may fail to develop or grow properly.
Approximately half of all patients with ulcerative colitis have
relatively mild symptoms. However, others may suffer from severe
abdominal cramping, bloody diarrhea, nausea, and fever. The symptoms of
ulcerative colitis do tend to come and go, with fairly long periods in
between flare-ups in which patients may experience no distress at all.
These periods of remission can span months or even years, although
symptoms do eventually return. The unpredictable course of ulcerative
colitis may make it difficult for physicians to evaluate whether a
particular course of treatment has been effective or not.
Source: Crohn's & Colitis Foundation of America
www.ccfa.org
To learn more about clinical trials being conducted by Otsuka, please visit the U.S. National Institute of Health clinical trials registry website,
www.clinicaltrials.gov.
|